I strongly believe that genotyping will provide the answers to finding optimal treatments for patients with paroxysmal
pain disorders and I am looking forward to continuing and building on our existing strong and exciting collaboration.
dystonia is frequently seen in the lesions involving the basal ganglia, extrapyramidal tract system, or thalamus.
Data Source: The MANTRA-PAF study, which randomized 294 patients with paroxysmal
atrial fibrillation to initial treatment with catheter ablation or drug treatment and followed them for 2 years.
Narrative review: paroxysmal
nocturnal hemoglobinuria: the physiology of complement-relat-ed hemolytic anemia.
positional vertigo (BPPV): idiopathic versus post-traumatic.
Food and Drug Administration for the treatment of drug refractory recurrent symptomatic paroxysmal
atrial fibrillation when used with CARTO(R) Navigation Systems.
torticollis of infancy: four new cases and linkage to CACNA1A mutation.
nocturnal haemoglobinuria: long-term follow-up and prognostic factors.
Soliris, a designated orphan medicinal product, is intended to reduce hemolysis (destruction of red blood cells) in patients with paroxysmal
nocturnal hemoglobinuria (PNH), The CHMP recommended a broad label for Soliris covering all patients with PNH.
Reader: I am 52 years old and have episodes of paroxysmal
A 52-year-old male chemical worker was admitted to the hospital with a history of paroxysmal
microscopic hematuria for about 2 years and nocturia with gross hematuria about five times per night for 2 months.
Researchers led by scientists at The Cleveland Clinic (Cleveland, OH) have identified the first gene in patients who have epilepsy associated with a movement disorder called paroxysmal